Table 1.
MiRNAs of importance for β-cell failure
| β-Cell failure | |
|---|---|
| miRNAs | Effects |
| miR-7 | Represses β-cell function,34 regulates GLP-1-mediated insulin release.49 |
| miR-9 | Represses β-cell function.37 |
| miR-15a | Regulates insulin synthesis.33 |
| miR-17-92 cluster | Regulates β-cell replication, restoration and adaptation, and GSIS.24 |
| miR-24 | Reduces insulin promoter activity and insulin mRNA levels and consequently insulin content.33,39 |
| miR-25 | Its overexpression leads to inhibition of insulin biosynthesis and increased β-cell apoptosis.27 |
| miR-26 | Reduces insulin promoter activity and insulin mRNA levels and consequently insulin content.33,39 |
| miR-29 family | Its overexpression negatively affects GSIS and β-cell proliferation.45 |
| miR-30d | Increases insulin gene expression.32 |
| miR-34a | Its overexpression results in sensitization to apoptosis and impaired nutrient-induced insulin secretion.26 |
| miR-92b | Its overexpression leads to inhibition of insulin biosynthesis and increased β-cell apoptosis.27 |
| miR-96 | Represses β-cell function.38 |
| miR-124a | Promotes β-cell dysfunction and death.43 |
| miR-125b-5p | Its down-regulation reduces insulin sensitivity and deregulates β-cell function.46 |
| miR-130a/b | Negatively correlated with insulin exocytosis.15 |
| miR-132 | Controls β-cell identity,48 proliferation and survival,51 regulates GLP-1-mediated insulin release.50 |
| miR-146 | Its overexpression results in sensitization to apoptosis and impaired nutrient-induced insulin secretion.26 |
| miR-148 | Reduces insulin promoter activity and insulin mRNA levels and consequently insulin content.33,39 |
| miR-152 | Negatively correlated with insulin exocytosis.15 |
| miR-153 | Its overexpression induces insulin secretion defects.28 |
| miR-181b | Regulates β-cell replication and GSIS.24 |
| miR-182 | Reduces insulin promoter activity and insulin mRNA levels and consequently insulin content.33,39 |
| miR-187 | Negatively correlated with GSIS.42 |
| miR-200 family | Represses β-cell function.35,166 |
| miR-204 | Blocks insulin production,47 promotes β-cell ER stress.52 |
| miR-212 | Regulates GLP-1-mediated insulin release.50 |
| miR-216a | Its knockout leads to a reduction in islet size, β-cell mass, and insulin levels.25 |
| miR-223 | Its overexpression drives the compensatory β-cell expansion and the maintenance of functional β-cell mass during metabolic stress.22 |
| miR-299-5p | Its reduction promotes β-cell dysfunction and loss.31 |
| miR-320a | Its overexpression initiates pancreatic islet dysfunction by increasing the ROS level, inhibiting proliferation, and inducing apoptosis.29 |
| miR-335 | Negatively correlated with insulin exocytosis.41 |
| miR-375 | Regulates β-cell adaptation to metabolic stress and insulin resistance19 and promotes GSIS33 |
| miR-383 | Its overexpression reverses β-cell apoptosis and oxidative stress.30 |
| miR-455 | Its overexpression drives the compensatory β-cell expansion and the maintenance of functional β-cell mass during metabolic stress.23 |
| miR-770-5p | Promotes β-cell dysfunction and death.44 |
ER, endoplasmic reticulum; GLP-1, glucagon-like peptide-1; GSIS, glucose-stimulated insulin secretion; miRNA, microRNA; mRNA, messenger RNA; ROS, reactive oxygen species.